| Ytd | 30.07% | |
| 1y | 29.39% |
| Open | 260.72 | Prev Close | 259.47 | Low | 257.06 | High | 263.46 | Mkt Cap | 20.81B |
| Vol | 426.76K | Avg Vol | 974.83K | EPS | 25.97 | P/E | 9.95 | Forward P/E | 12.26 |
| Beta | 1.20 | Short Ratio | 2.75 | Inst. Own | 101.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 03-13 | Earning | 10-29 | 50-d Avg | 262.56 | 200-d Avg | 214.11 | 1yr Est | 284.64 |
Tenet Healthcare (NYSE:THC) has outperformed the market over the past 15 years by 6.23% on an annual
https://www.ftc.gov/news-events/news/press-releases/2026/10/ftc-issues-letters-warning-hospitals-aga
Astrana Health (NASDAQ: ASTH - Get Free Report) and Tenet Healthcare (NYSE: THC - Get Free Report) a
Tenet Healthcare (THC) reached $258.62 at the closing of the latest trading day, reflecting a +1.83%
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 202
Tenet Healthcare's stronger cash flow is fueling bigger buybacks, but growth investments and capital
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
Tenet Healthcare (NYSE:THC) has outperformed the market over the past 10 years by 14.65% on an annua
Junk bond yields surpassed 15%, the highest since 2022. These 10 stocks with bonds in XCCC carry $97
BMO Capital analyst Sean Dodge initiates coverage on Tenet Healthcare (NYSE:THC) with a Market Pe
Tenet Healthcare (NYSE:THC) has outperformed the market over the past 5 years by 17.9% on an annuali